HOME >> BIOLOGY >> NEWS
The promise of new medical uses for sodium nitrite for heart attack and organ damage

tissue damage and cell death that can occur in conjunction with organ transplantation, heart attack, and treatment of a heart attack.

In both the liver and heart components of the current study, the research team compared the effects of both lower and higher concentrations of nitrite versus control treatments of saline or nitrate, a chemical compound that is related to nitrite but cannot convert to NO in the blood. Surprisingly, they found that only low concentrations of nitrite provided protection against injury.

The investigators are currently studying the mechanism for the protective effect of sodium nitrite and they believe it is related in some way to the conversion of nitrite to nitric oxide.

"The remarkable thing about nitrite is that it is only converted to nitric oxide in the organs and tissues with the lowest oxygen levels, allowing for targeted NO delivery and thus improved blood flow -- to tissues under stress. More research is needed to look at the effectiveness of nitrite in various organs and disease states in humans," said NHLBI's Gladwin who is also an investigator in the Critical Care Medicine Department, NIH Clinical Center.

Gladwin is currently studying the use of sodium nitrite as a way to help adults with sickle cell disease. It is hoped that this treatment will reverse the effect of decreased blood flow due to the patients' "sickled" blood cells. Patients with sickle cell disease have abnormal hemoglobin molecules in their red blood cells. The molecules damage the red cells, causing them to change into a crescent or sickle shape and stick to blood vessel walls. This can lead to narrowed, or blocked, blood vessels leading to pain, damage, and anemia.

Further studies either underway or in planning translate the new findings to humans. These studies evaluate sodium nitrite's effect on heart attacks, kidney failure, solid organ transplantation, cerebral vasospasm (a complication
'"/>

Contact: NHLBI Communications Office
nhlbi_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung, and Blood Institute
14-Apr-2005


Page: 1 2 3

Related biology news :

1. Insulin grown in plants relieves diabetes in mice; UCF study holds promise for humans
2. Radiation therapy combined with microsurgery shows promise for curing injured spinal cord
3. New proteomics research promises to revolutionize biomedical discovery
4. New research holds promise for protecting cancer patients against infertility
5. New approach to pulmonary hypertension shows promise
6. Modular leukemia drug shows promise in early testing
7. Hepatitis B drug can compromise HIV treatment
8. UCF nanoparticle offers promise for treating glaucoma
9. Identification of genetic risk factor for coeliac disease promises improved treatment
10. Canadian paper innovation holds promise for improved global health safety
11. Bacteria show promise in fending off global amphibian killer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/30/2019)... ... September 30, 2019 , ... ... of innovative human mesenchymal stem/stromal cell (hMSC) biomanufacturing systems, today announced it ... “Ready-to-Print” (RTP) cellular product formats (patent number AU 2015259373). This new patent ...
(Date:9/25/2019)... ... 25, 2019 , ... The esteemed dental implant specialists at ... for a variety of procedures, including single tooth replacement, new “teeth-in-a-day” immediately functioning ... implants offer patients permanent tooth replacement solutions that look and function very ...
(Date:9/25/2019)... ... September 25, 2019 , ... ... collaboration and dialogue, today announces its inaugural South CEO conference to ... Louisiana. , Co-produced by Tulane University, this invitation-only meeting convenes biopharma executives ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it has added ... 18-19th, 2019 in Las Vegas with spots still open. , The speaker, Dr. Ian ... Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as the Chief ...
(Date:10/8/2019)... ... 2019 , ... Erchonia Corporation, the global leader in the ... the U.S. Food and Drug Administration (FDA) has granted the company 510(k) market ... chronic neck and shoulder pain of musculoskeletal origin. , Erchonia continues to be ...
(Date:10/3/2019)... ... 2019 , ... Cheyenne is a beautiful and strong Quarter Horse and a ... Rebel’s Run , which offers riding lessons and trail riding in Afton, Virginia. ... Mimi describes her as her “go to horse.” Thus, you can imagine ...
(Date:10/3/2019)... Va. (PRWEB) , ... October 02, 2019 , ... eKare’s ... prestigious NHS Digital Health Accelerator run by the East Midlands Academic Health Science Network ... the adoption of technology in NHS by providing support to develop and deploy solutions ...
Breaking Biology Technology:
Cached News: